Biotech | November 05, 2021
Novavax files emergency use listing with WHO for Covid-19 vaccine
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
It recommends using the vaccine to prevent the spread of the disease
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
It is a recombinant nanoparticle protein-based vaccine
Crosscope and KFBIO join forces to lead digital transformation for pathology in India and emerging markets
The World Health Organisation (WHO), has felt the need to conduct this training to build local capacities in poor countries to bridge the gap and enhance local production
Subscribe To Our Newsletter & Stay Updated
